![Logo for Geron Corporation](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-icons%2Fb9b7c-2022-09-28-11-00-07.png&w=256&q=100)
Geron Investor Relations Material
Latest events
![Logo for Geron Corporation](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-icons%2Fb9b7c-2022-09-28-11-00-07.png&w=128&q=100)
FDA Announcement
Geron
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Geron Corporation
Access all reports
Geron Corporation focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. The company has a portfolio of drugs in clinical trials that address a number of blood cancers, including acute myeloid leukemia (AML) and Acute Lymphoblastic Leukemia (ALL). In AML, it develops GRN163L/GRN163L-AQ, which is an oral small molecule Bruton's tyrosine kinase inhibitor (BTKi) initially planned for regulatory filing in the U.S., Canada, and Europe in the third quarter 2014 to treat patients with previously treated AML with FLT3 -ITD or V617F mutation and in the fourth quarter 2014 to treat patients with relapsed or refractory pediatric AML with FLT3-ITD or V617F mutation; GRN703/GRN703-AQ, an oral inhibitor of both Btk and IgE Fcepsilon receptors (FCER1A), which is being developed to treat patients with eosinophil-related diseases, including allergic asthma and atopic dermatitis.
Key slides for Geron Corporation
![Starting Treatment w](/_next/image?url=https%3A%2F%2Fcdn.quartr.com%2Fimages%2Fconference-calls%2Fgeron-corporation-fda-announcement-d0309dc24c86fdb9%2F17.png&w=3840&q=75)
![Logo for Geron Corporation](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-icons%2Fb9b7c-2022-09-28-11-00-07.png&w=128&q=100)
FDA Announcement
Geron Corporation
![Financial Resources](/_next/image?url=https%3A%2F%2Fcdn.quartr.com%2Fimages%2Fconference-calls%2Fgeron-corporation-q1-2024-bc49cadc5e22a4c7%2F18.png&w=3840&q=75)
![Logo for Geron Corporation](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-icons%2Fb9b7c-2022-09-28-11-00-07.png&w=128&q=100)
Q1 2024
Geron Corporation
Latest articles
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F1882x1059%2F7e17876154%2Fbirkin.png&w=3840&q=75)
The Birkin Bag: The Story Behind the World's Most Desired Handbag
How the Birkin bag became the world's most sought-after handbag where even the wealthy must earn the right to own one.
12 Jul 2024
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F2688x1512%2F8365aa8316%2Ftop-10-largest-semiconductor-companies.png&w=3840&q=75)
The 10 Largest Semiconductor Companies in the World
Discover the top 10 semiconductor companies by market cap, exploring their innovations and business models shaping the tech landscape.
10 Jul 2024
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F2000x1125%2F135c0e3f6b%2Fthe-rise-of-nubank.png&w=3840&q=75)
The Rise of Nubank: Changing Latin American Finance
Discover how Nubank revolutionized Latin American banking with innovation, backed by top investors like Berkshire Hathaway.
9 Jul 2024
Ticker symbol
GERN
Country
🇺🇸 United States